Loading…
Myosin in autoinhibited off state(s), stabilized by mavacamten, can be recruited in response to inotropic interventions
Mavacamten is a FDA-approved small-molecule therapeutic designed to regulate cardiac function at the sarcomere level by selectively but reversibly inhibiting the enzymatic activity of myosin. It shifts myosin toward ordered states close to the thick filament backbone. It remains elusive whether thes...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS 2024-02, Vol.121 (8), p.e2314914121 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Mavacamten is a FDA-approved small-molecule therapeutic designed to regulate cardiac function at the sarcomere level by selectively but reversibly inhibiting the enzymatic activity of myosin. It shifts myosin toward ordered
states close to the thick filament backbone. It remains elusive whether these myosin heads in the
state(s) can be recruited in response to physiological stimuli when required to boost cardiac output. We show that cardiac myosins stabilized in these
state(s) by mavacamten are recruitable by 1) Ca
, 2) increased chronotropy [heart rate (HR)], 3) stretch, and 4) β-adrenergic (β-AR) stimulation, all known physiological inotropic interventions. At the molecular level, we show that Ca
increases myosin ATPase activity by shifting mavacamten-stabilized myosin heads from the inactive super-relaxed state to the active disordered relaxed state. At the myofilament level, both Ca
and passive lengthening can shift mavacamten-ordered
myosin heads from positions close to the thick filament backbone to disordered
states closer to the thin filaments. In isolated rat cardiomyocytes, increased stimulation rates enhanced shortening fraction in mavacamten-treated cells. This observation was confirmed in vivo in telemetered rats, where left-ventricular dP/dt
an index of inotropy, increased with HR in mavacamten-treated animals. Finally, we show that β-AR stimulation in vivo increases left-ventricular function and stroke volume in the setting of mavacamten. Our data demonstrate that the mavacamten-promoted
states of myosin in the thick filament are at least partially activable, thus preserving cardiac reserve mechanisms. |
---|---|
ISSN: | 0027-8424 1091-6490 1091-6490 |
DOI: | 10.1073/pnas.2314914121 |